Benjamin F. Edwards & Company, Inc. Staar Surgical CO Transaction History

Benjamin F. Edwards & Company, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$30.6 - $43.78 $7,650 - $10,945	250 Added 110.13%	477 $15,000
Q3 2023 Nov 13, 2023	SELL	$39.39 - $58.12 $9,847 - $14,530	-250 Reduced 52.41%	227 $9,000
Q2 2022 Aug 12, 2022	SELL	$50.24 - $80.48 $12,560 - $20,120	-250 Reduced 34.39%	477 $34,000
Q3 2021 Nov 02, 2021	BUY	$122.75 - $162.68 $122 - $162	1 Added 0.14%	727 $93,000
Q4 2020 Feb 16, 2021	SELL	$55.93 - $82.78 $55,930 - $82,780	-1,000 Reduced 57.94%	726 $58,000
Q3 2020 Nov 13, 2020	BUY	$45.65 - $61.81 $67,379 - $91,231	1,476 Added 590.4%	1,726 $98,000
Q2 2020 Aug 14, 2020	BUY	$29.15 - $61.54 $7,287 - $15,385	250 New	250 $15,000

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.